𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cognitive impairment in Parkinson's disease: Tools for diagnosis and assessment

✍ Scribed by Jaime Kulisevsky; Javier Pagonabarraga


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
94 KB
Volume
24
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Cognitive impairment (CI) and dementia are frequent and debilitating features associated with Parkinson's disease (PD). Formal neuropsychological examination is required to ascertain the degree and pattern of CI over the course of the disease. The use of different tools may explain heterogeneous data obtained from studies to date. Normative data for extensively used scales [Mattis Dementia Rating Scale (MDRS), Mini‐Mental State Examination (MMSE)] is incomplete in PD populations. According to sample characteristics, statistical analyses, and methodological quality, 33 studies using scales not specific to PD (MDRS, MMSE, Cambridge Cognitive Assessment, FAB) or PD‐specific scales (Mini‐Mental Parkinson, Scales for Outcomes of Parkinson's disease—Cognition, Parkinson's Disease—Cognitive Rating Scale, and Parkinson Neuropsychometric Dementia Assessment) were eligible for the critical analysis of their appropriateness to assess cognition in PD. Of the four scales specifically designed for PD, the SCOPA‐COG and the PD‐CRS have undergone extensive and rigorous validation processes. While the SCOPA‐COG mainly assesses “frontal‐subcortical” cognitive defects, the PD‐CRS also assesses “instrumental‐cortical” functions, allowing better characterization of the different patterns of CI that may be present in PD from the earliest stages. The MMP and PANDA scales were designed as brief screening tests for CI and have not yet been subjected to extensive clinimetric evaluations. Further research on PD‐specific tools seems mandatory to help establish accurate cut‐off scores for the diagnosis of mild PDD, detect cognitive profiles more prone to the future development of dementia, and allow comparisons between different descriptive or interventional studies. © 2009 Movement Disorder Society


📜 SIMILAR VOLUMES


The montreal cognitive assessment as a s
✍ David J. Gill; Arielle Freshman; Jennifer A. Blender; Bernard Ravina 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

## Abstract Cognitive impairment is common in Parkinson's disease (PD) and can occur early in the disease course. No effective screening test exists for detection of early or mild cognitive impairment in PD. We examined the Montreal Cognitive Assessment (MoCA) as a screening tool for cognitive dysf

MRI and cognitive impairment in Parkinso
✍ Naroa Ibarretxe-Bilbao; Eduardo Tolosa; Carme Junque; Maria-Jose Marti 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 1 views

## Abstract Patients with Parkinson's disease (PD) may present impairment in cognitive functions even at early stages of the disease. When compared with the general population, their risk of dementia is five to six times higher. Recent investigations using structural MRI have shown that dementia in

Cognitive impairment and dementia in Par
✍ Karen Marder 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 1 views

## Abstract Over the last decade, the importance of cognitive impairment and dementia in Parkinson's disease (PDD) has been increasingly recognized. Investigators have proposed criteria for PD dementia, and mild cognitive impairment. Risk profiles associated with the development of dementia based o

Cognitive impairment in nondemented Park
✍ Paolo Barone; Dag Aarsland; David Burn; Murat Emre; Jaime Kulisevsky; Daniel Wei 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB 👁 1 views

## Abstract A substantial percentage of patients with newly diagnosed Parkinson's disease without dementia are reported to be affected by cognitive impairment (CI). In practice, however, CI is underrecognized, as the signs may not be apparent in early‐stage disease and many routine assessment tools

Cognitive impairment in Parkinson's dise
✍ Javier Rodríguez-Ferreiro; Fernando Cuetos; Elena Herrera; Manuel Menéndez; René 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

## Abstract Some degree of cognitive impairment appears frequently in Parkinson's disease (PD) patients, even at the onset of the disease. However, due to the heterogeneity of the patients and the lack of standardized assessment batteries, it remains unclear which capacities are primarily affected

Characterizing mild cognitive impairment
✍ John C. Dalrymple-Alford; Leslie Livingston; Michael R. MacAskill; Charlotte Gra 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 343 KB 👁 1 views

## Abstract There is growing interest in identifying Parkinson's disease (PD) patients with mild cognitive impairment (PD‐MCI), but widely disparate criteria have been used. We assessed 143 PD patients and 50 matched controls on 20 measures across 4 cognitive domains (executive function, attention